扬州生物医药和新型医疗器械产业加速发展，这场发展大会恰逢其时

Core Insights - The conference on biotechnology in Jiangsu highlights the sector's role in national food security and the "Healthy China 2030" initiative, emphasizing its transformative impact on the global landscape [3] - Jiangsu's strong industrial foundation, talent resources, and favorable policies create a conducive environment for the development of the biotechnology industry, focusing on areas like synthetic biology, biomedicine, and gene editing [3] Industry Development - The biomedicine sector is a key focus in the construction of Yangzhou's modern industrial system, with reported revenues of 7.93 billion yuan and a year-on-year growth of 1.9% in the first three quarters of the year [3] - Tax revenue from the biomedicine and new medical device industries reached 480 million yuan, reflecting a significant year-on-year increase of 19.5% [3] - Yangzhou has implemented an innovation mechanism linking medical institutions with companies to accelerate project outcomes, resulting in the attraction of 39 technology-based enterprises and 40 projects exceeding 100 million yuan this year [3] Academic and Research Contributions - Yangzhou University is enhancing its life sciences programs, leveraging strengths in veterinary and crop sciences, and has established over 10 provincial and ministerial key laboratories [4] - The university's research team has achieved notable results in areas such as zoonotic disease prevention and biotechnological innovations [4] Future Goals - By 2026, Yangzhou aims to achieve a revenue target of over 15 billion yuan, with 130 large-scale enterprises and tax revenue exceeding 600 million yuan [4] - The city plans to deepen collaborations with top universities and leverage industry funds to attract leading enterprises and address challenges in financing and clinical transformation [4]